Literature DB >> 18537557

Label-free cell-based assays for GPCR screening.

Ye Fang1, Anthony G Frutos, Ronald Verklereen.   

Abstract

G protein-coupled receptors (GPCRs) have been proven to be the largest family of druggable targets in the human genome. Given the importance of GPCRs as drug targets and the de-orphanization of novel targets, GPCRs are likely to remain the frequent targets of many drug discovery programs. With recent advances in instrumentation and understanding of cellular mechanisms for the signals measured, biosensor-centered label-free cell assay technologies become a very active area for GPCR screening. This article reviews the principles and potential of current label-free cell assay technologies in GPCR drug discovery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537557     DOI: 10.2174/138620708784534789

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  25 in total

Review 1.  The significance of G protein-coupled receptor crystallography for drug discovery.

Authors:  John A Salon; David T Lodowski; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 2.  Blood-based diagnostics of traumatic brain injuries.

Authors:  Stefania Mondello; Uwe Muller; Andreas Jeromin; Jackson Streeter; Ronald L Hayes; Kevin K W Wang
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

3.  Resonant waveguide grating imager for live cell sensing.

Authors:  Ann M Ferrie; Qi Wu; Ye Fang
Journal:  Appl Phys Lett       Date:  2010-12-01       Impact factor: 3.791

4.  Inhibition of colonic motility and defecation by RS-127445 suggests an involvement of the 5-HT2B receptor in rodent large bowel physiology.

Authors:  A K Bassil; C M Taylor; V J N Bolton; K M Gray; J D Brown; L Cutler; S G Summerfield; G Bruton; W J Winchester; K Lee; G J Sanger
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

5.  Structure-Activity Study of Dihydrocinnamic Acids and Discovery of the Potent FFA1 (GPR40) Agonist TUG-469.

Authors:  Elisabeth Christiansen; Maria E Due-Hansen; Christian Urban; Nicole Merten; Michael Pfleiderer; Kasper K Karlsen; Sanne S Rasmussen; Mette Steensgaard; Alexandra Hamacher; Johannes Schmidt; Christel Drewke; Rasmus Koefoed Petersen; Karsten Kristiansen; Susanne Ullrich; Evi Kostenis; Matthias U Kassack; Trond Ulven
Journal:  ACS Med Chem Lett       Date:  2010-07-02       Impact factor: 4.345

6.  Label-Free Receptor Assays.

Authors:  Ye Fang
Journal:  Drug Discov Today Technol       Date:  2011

7.  PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS.

Authors:  Ye Fang
Journal:  Expert Opin Drug Discov       Date:  2010-12       Impact factor: 6.098

8.  Isothermal chemical denaturation to determine binding affinity of small molecules to G-protein coupled receptors.

Authors:  Patrick Ross; Wilhelm Weihofen; Fai Siu; Amy Xie; Hetal Katakia; S Kirk Wright; Ian Hunt; Richard K Brown; Ernesto Freire
Journal:  Anal Biochem       Date:  2014-12-04       Impact factor: 3.365

9.  C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assay.

Authors:  Edimara S Reis; Hui Chen; Georgia Sfyroera; Peter N Monk; Jörg Köhl; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2012-10-05       Impact factor: 5.422

10.  Label-free cell phenotypic assessment of the biased agonism and efficacy of agonists at the endogenous muscarinic M3 receptors.

Authors:  Huayun Deng; Haiyan Sun; Ye Fang
Journal:  J Pharmacol Toxicol Methods       Date:  2013-08-09       Impact factor: 1.950

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.